levetiracetam

Generic: levetiracetam

Labeler: cranbury pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam
Generic Name levetiracetam
Labeler cranbury pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

levetiracetam 250 mg/1

Manufacturer
Cranbury Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 27808-263
Product ID 27808-263_470fcaea-feb6-1488-e063-6294a90a581d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091491
Listing Expiration 2026-12-31
Marketing Start 2023-05-01

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 27808263
Hyphenated Format 27808-263

Supplemental Identifiers

RxCUI
311288 311289 311290 387003
UPC
0327808264015 0327808266019 0327808265012 0327808263018
UNII
44YRR34555
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number ANDA091491 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (27808-263-01)
  • 500 TABLET in 1 BOTTLE (27808-263-02)
source: ndc

Packages (2)

27808-263-01 120 TABLET in 1 BOTTLE (27808-263-01) 27808-263-02 500 TABLET in 1 BOTTLE (27808-263-02)

Ingredients (1)

levetiracetam (250 mg/1)

Linked Drug Pages (1)

Levetiracetam ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "470fcaea-feb6-1488-e063-6294a90a581d", "openfda": {"nui": ["N0000008486"], "upc": ["0327808264015", "0327808266019", "0327808265012", "0327808263018"], "unii": ["44YRR34555"], "rxcui": ["311288", "311289", "311290", "387003"], "spl_set_id": ["b1e988f7-8bbe-4ef4-8b0a-b2a8af8a482b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Cranbury Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (27808-263-01)", "package_ndc": "27808-263-01", "marketing_start_date": "20230501"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (27808-263-02)", "package_ndc": "27808-263-02", "marketing_start_date": "20230501"}], "brand_name": "Levetiracetam", "product_id": "27808-263_470fcaea-feb6-1488-e063-6294a90a581d", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "27808-263", "generic_name": "Levetiracetam", "labeler_name": "Cranbury Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "250 mg/1"}], "application_number": "ANDA091491", "marketing_category": "ANDA", "marketing_start_date": "20230501", "listing_expiration_date": "20261231"}